Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 18, 2026Nanomedicine

Controlling nanoparticle targeting: from physicochemical design to molecular recognition

View Full Paper
Ask AI
Bookmark
Share

Authors

ARA. RocchiLMLuca MarchettiPDPaolo Decuzzi

Discussion

Loading...

Member takes

Overview

This randomized trial evaluates nanoparticle targeting strategies in nanomedicine, highlighting their potential for improved therapeutic outcomes.

Key Points

  • The aim is to examine how nanoparticle design influences targeting and therapeutic efficacy in various diseases.
  • Critical examination of nanoparticle targeting strategies and functionalization approaches.
  • Discussion of physicochemical properties influencing drug delivery efficacy.
  • Analysis of the impact of biological interactions such as protein corona and immune response on targeting.
  • Various targeting strategies enhance biodistribution and therapeutic insights.
  • Stimuli-responsive platforms significantly improve drug release and targeting precision.
  • Macrophage hitchhiking demonstrates both challenges and opportunities for nanoparticle delivery.

Cite This Study

Rocchi et al. (2026) studied this question.

synapsesocial.com/papers/6a338e14630953a74978ebfdhttps://doi.org/10.1080/17435889.2026.2688999
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Engineering strategies and translational progress in targeted nanoparticle drug delivery2026
  2. 2Advancements in nanoparticle applications for targeted drug delivery: benefits and implications2024 · 2 citations
  3. 3Nanoparticles for Drug Delivery: Design, Mechanisms, and Clinical Translation2026
  4. 4The Reality of Active Targeting in Nanomedicine: Promise Versus Performance2026
  5. 5NANOPARTICLES AS TARGETED DRUG DELIVERY SYSTEMS: RECENT ADVANCES AND FUTURE PERSPECTIVES2026